Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research
ClinicalTrials.gov Identifier:
NCT00031889
First received: March 8, 2002
Last updated: May 14, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)